Pharmacologic potential of new nitro-compounds as antimicrobial agents against nosocomial pathogens: design, synthesis, and in vitro effectiveness

[1]  M. Saki,et al.  A review on mechanism of action, resistance, synergism, and clinical implications of mupirocin against Staphylococcus aureus. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[2]  Junpeng Zhang,et al.  Impact of biofilm formation and detachment on the transmission of bacterial antibiotic resistance in drinking water distribution systems. , 2018, Chemosphere.

[3]  E. Septimus.  Antimicrobial Resistance: An Antimicrobial/Diagnostic Stewardship and Infection Prevention Approach. , 2018, The Medical clinics of North America.

[4]  W. Lima,et al.  Design, synthesis, biological activity and structure-activity relationship studies of chalcone derivatives as potential anti-Candida agents , 2018, The Journal of Antibiotics.

[5]  W. Lima,et al.  Chromosomally encoded and plasmid-mediated polymyxins resistance in Acinetobacter baumannii: a huge public health threat , 2018, European Journal of Clinical Microbiology & Infectious Diseases.

[6]  W. Lima,et al.  Phytochemical characterisation and bioprospection for antibacterial and antioxidant activities of Lippia alba Brown ex Britton & Wilson (Verbenaceae) , 2018, Natural product research.

[7]  W. Lima,et al.  Absence of antibacterial, anti-candida, and anti-dengue activities of a surfactin isolated from Bacillus subtilis , 2018 .

[8]  H. S. Rosenzweig,et al.  The antitubercular activity of various nitro(triazole/imidazole)-based compounds. , 2017, Bioorganic & medicinal chemistry.

[9]  D. S. Arora,et al.  Synthesis of 5-nitro-salicylaldehyde-N-substituted thiosemicarbazonates of copper(II): Molecular structures, spectroscopy, ESI-mass studies and antimicrobial activity , 2017 .

[10]  WHO PUBLISHES LIST OF BACTERIA FOR WHICH NEW ANTIBIOTICS ARE URGENTLY NEEDED , 2017, Saudi Medical Journal.

[11]  M. Ay,et al.  Biological evaluation and molecular docking studies of nitro benzamide derivatives with respect to in vitro anti‐inflammatory activity , 2017, International immunopharmacology.

[12]  M. Cecchini,et al.  Ultrastructural Characterization of the Lower Motor System in a Mouse Model of Krabbe Disease , 2016, Scientific Reports.

[13]  M. Hanif,et al.  Synthesis, crystal structure, structural characterization and in vitro antimicrobial activities of 1-methyl-4-nitro-1H-imidazole , 2016 .

[14]  P. Lu,et al.  Isolation of Live Premature Senescent Cells Using FUCCI Technology , 2016, Scientific Reports.

[15]  Y. Lyu,et al.  Antimicrobial activity, improved cell selectivity and mode of action of short PMAP-36-derived peptides against bacteria and Candida , 2016, Scientific Reports.

[16]  M. Villetti,et al.  Antimicrobial photodynamic effect of phenothiazinic photosensitizers in formulations with ethanol on Pseudomonas aeruginosa biofilms. , 2016, Photodiagnosis and photodynamic therapy.

[17]  J. Premanandh,et al.  Race Against Antimicrobial Resistance Requires Coordinated Action – An Overview , 2016, Front. Microbiol..

[18]  G. Besra,et al.  Novel derivatives of nitro-substituted salicylic acids: Synthesis, antimicrobial activity and cytotoxicity. , 2015, Bioorganic & medicinal chemistry.

[19]  M. Seleem,et al.  Exploring simvastatin, an antihyperlipidemic drug, as a potential topical antibacterial agent , 2015, Scientific Reports.

[20]  H. Ferraz,et al.  The Triterpenoid Betulin Protects against the Neuromuscular Effects of Bothrops jararacussu Snake Venom In Vivo , 2015, Evidence-based complementary and alternative medicine : eCAM.

[21]  Aftab Ahmad,et al.  Nosocomial infections and their control strategies , 2015 .

[22]  J. Barbosa-Filho,et al.  Evaluation of Antifungal Activity and Mode of Action of New Coumarin Derivative, 7-Hydroxy-6-nitro-2H-1-benzopyran-2-one, against Aspergillus spp. , 2015, Evidence-based complementary and alternative medicine : eCAM.

[23]  P. Vicini,et al.  A New Efficient Route to 7‐Aryl‐6‐fluoro‐8‐nitroquinolones as Potent Antibacterial Agents. , 2015 .

[24]  G. Braus,et al.  One Juliet and four Romeos: VeA and its methyltransferases , 2015, Front. Microbiol..

[25]  K. Lewis,et al.  A new antibiotic kills pathogens without detectable resistance , 2015, Nature.

[26]  A. Shafiee,et al.  Synthesis, in vitro cytotoxicity and apoptosis inducing study of 2-aryl-3-nitro-2H-chromene derivatives as potent anti-breast cancer agents. , 2014, European journal of medicinal chemistry.

[27]  P. Vicini,et al.  A new efficient route to 7-aryl-6-fluoro-8-nitroquinolones as potent antibacterial agents. , 2014, European journal of medicinal chemistry.

[28]  Kerly F. M. Pasqualoto,et al.  Exploring 5-nitrofuran derivatives against nosocomial pathogens: synthesis, antimicrobial activity and chemometric analysis. , 2014, Bioorganic & medicinal chemistry.

[29]  M. Al-Dosari,et al.  Synthesis and anti-Candidal activity of N-(4-aryl/cyclohexyl)-2-(pyridine-4-yl carbonyl) hydrazinecarbothioamide. , 2014, Bioorganic & medicinal chemistry letters.

[30]  Z. Chohan,et al.  In vitro antibacterial, antifungal and cytotoxic activities of some triazole Schiff bases and their oxovanadium(IV) complexes , 2013, Journal of enzyme inhibition and medicinal chemistry.

[31]  Virander S. Chauhan,et al.  Mechanism of action of novel synthetic dodecapeptides against Candida albicans. , 2013, Biochimica et biophysica acta.

[32]  Marcelo Zaldini Hernandes,et al.  Halogen atoms in the modern medicinal chemistry: hints for the drug design. , 2010, Current drug targets.

[33]  N. Geweely.  Anticandidal cytotoxicity, antitumor activities, and purified cell wall modulation by novel Schiff base ligand and its metal (II) complexes against some pathogenic yeasts , 2009, Archives of Microbiology.

[34]  U. Theuretzbacher,et al.  Future antibiotics scenarios: is the tide starting to turn? , 2009, International journal of antimicrobial agents.

[35]  S. Gaonkar,et al.  Synthesis of New Series of 5,6‐Dihydro‐4H‐1,2‐oxazines via Hetero Diels—Alder Reaction and Evaluation of Antimicrobial Activity. , 2009 .

[36]  S. Zacchino,et al.  Evidence for the mechanism of action of the antifungal phytolaccoside B isolated from Phytolacca tetramera Hauman. , 2008, Journal of natural products.

[37]  D. Motghare,et al.  Antimicrobial Resistance Among Nosocomial Isolates in a Teaching Hospital in Goa , 2008, Indian journal of community medicine : official publication of Indian Association of Preventive & Social Medicine.

[38]  D. Cardo,et al.  Estimating Health Care-Associated Infections and Deaths in U.S. Hospitals, 2002 , 2007, Public health reports.

[39]  K. Wanner,et al.  Methods and Principles in Medicinal Chemistry , 2007 .

[40]  A. Remmal,et al.  Surface alteration of Saccharomyces cerevisiae induced by thymol and eugenol , 2004, Letters in applied microbiology.

[41]  S. Ishihara,et al.  Dissection of upstream regulatory components of the Rho1p effector, 1,3-beta-glucan synthase, in Saccharomyces cerevisiae. , 2002, Genetics.

[42]  H. Waterbeemd,et al.  Pharmacokinetics and Metabolism in Drug Design: Smith: Pharmacokinetics , 2001 .

[43]  M. Ghannoum,et al.  Antifungal Agents: Mode of Action, Mechanisms of Resistance, and Correlation of These Mechanisms with Bacterial Resistance , 1999, Clinical Microbiology Reviews.

[44]  J. Vincent,et al.  The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. , 1995, JAMA.

[45]  David W Williams,et al.  Investigation of the value of β-glucan-specific fluorochromes for predicting the β-glucan content of the cell walls of zoopathogenic fungi , 1994 .

[46]  T. Meshulam,et al.  Serum-induced lysis ofPseudomonas aeruginosa , 1982, European Journal of Clinical Microbiology.

[47]  W. C. Still,et al.  Rapid chromatographic technique for preparative separations with moderate resolution , 1978 .

[48]  C. Carollo,et al.  Antibacterial and antifungal activities of phenolic compound-enriched ethyl acetate fraction from Cochlospermum regium (mart. Et. Schr.) Pilger roots: Mechanisms of action and synergism with tannin and gallic acid , 2018 .

[49]  S. Gaonkar,et al.  Synthesis of new series of 5,6-dihydro-4H-1,2-oxazines via hetero Diels-Alder reaction and evaluation of antimicrobial activity. , 2009, European journal of medicinal chemistry.

[50]  J. Bartlett,et al.  Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[51]  Clinical,et al.  Reference method for broth dilution antifungal susceptibility testing of yeasts : Approved standard , 2008 .

[52]  L. Nicolle,et al.  Prevention of hospital acquired infections: a practical guide. , 2002 .

[53]  Mary Jane Ferraro,et al.  Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : approved standard , 2000 .

[54]  A. Benenson.  Control of communicable diseases manual , 1995 .

[55]  J. Alexander,et al.  Nosocomial infections. , 1973, Current problems in surgery.

[56]  Identification and Characterization of a Novel Family of Selective Antifungal Compounds (CANBEFs) That Interfere with Fungal Protein Synthesis , 2022 .